For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
|
| Basic information |
| Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
| Ken-Shwo Dai |
Ken-Shwo Dai |
bobo |
(03)518-1918 |
No.335, Sec. 6, Zhonghua Rd.,Hsinchu City 30094, Taiwan |
2013/10/24 |
| Industrycategory |
Key businesses |
| Biotechnology and Medical Care |
VISGENEER is a biotech company located in Hsinchu, Taiwan, and is granted as
an "Enterprises in the Newly Emerging, Important and Strategic Industries " by
the ministry of Economic Affairs. Visgeneer aims to develop and produce
biomedical products associated with human diseases (cancer, cardiovascular
disease, diabetes and gout etc.) and skin aging.
Visgeneer (ISO13485:2003) has produced a fast, low sample volume and portable
biosensor for monitoring blood glucose level and we are also actively
participated in the development of tele-health blood glucose monitoring system.
Visgeneer (ISO22716:2007; ISO9001:2008) has utilized highly purified water as
a carrier in combination of several functional animal/plant extracts to
produce high quality skin care cosmetic products to satisfy the needs of all
ages. |
| Financial data |
| Cash flows statement
| Item
|
|
|
| Amount(NTD, in thousands) |
| Cash flows from operating activities |
|
|
| Cash flows from investing activities |
|
|
| Cash flows from financing activities |
|
|
Consolidated/Individual
balance sheet
|
Current assets |
|
|
| Non-current assets |
|
|
| Total assets |
|
|
| Current liabilities |
|
|
| Non-current liabilities |
|
|
| Total liabilities |
|
|
| Share capital |
|
|
| Capital surplus |
|
|
| Retained earnings |
|
|
| Other equity interest |
|
|
| Treasury shares |
|
|
| Total equity attributable to owners of parent |
|
|
| Non-controlling interests |
|
|
| Total equity |
|
|
| Book Value per share(NT$) |
|
|
Consolidated/Individual
profit and loss
statement |
Operating revenue |
|
|
| Operating costs |
|
|
| Gross profit from operations |
|
|
| Operating expenses |
|
|
| Net other income (expenses) |
|
|
| Net operating income |
|
|
| Non-operating income and expenses |
|
|
| Profit before tax |
|
|
| Tax expense |
|
|
| Profit from continuing operations |
|
|
| Profit from discontinued operations |
|
|
| Profit |
|
|
| Other comprehensive income |
|
|
| Comprehensive income |
|
|
| Basic earnings per share |
|
|
 Auditor's report on latest financial statements： auditor's report：
|
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|
